Globus Medical (GMED) Gross Profit (2011 - 2026)

Globus Medical (GMED) has reported Gross Profit for 16 consecutive years, with $548.2 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Gross Profit rose 10.39% year-over-year to $548.2 million; the trailing twelve-month figure through Jun 2026 stood at $2.2 billion (up 30.78% YoY), and the FY2025 full-year result was $2.0 billion, up 33.51% from the prior year.
• Gross Profit advanced to $548.2 million in Q2 2026 per GMED's latest filing, from $525.8 million in the prior quarter.
• Across five years, Gross Profit topped out at $565.3 million in Q4 2025 and bottomed at $171.4 million in Q1 2022.
• Historically, Gross Profit has averaged $351.0 million across 5 years, with a median of $360.2 million in 2024.
• The sharpest annual moves came in 2022 and 2024: Gross Profit fell 0.54% in 2022, then jumped 77.39% in 2024.
• Over 5 years, Gross Profit stood at $203.9 million in 2022, then surged by 72.16% to $351.0 million in 2023, then advanced by 12.19% to $393.9 million in 2024, then soared by 43.53% to $565.3 million in 2025, then dropped by 3.03% to $548.2 million in 2026.
• According to Business Quant data, Gross Profit over the past three periods registered $548.2 million, $525.8 million, and $565.3 million for Q2 2026, Q1 2026, and Q4 2025 respectively.